Renin-Angiotensin System Blockade in Acute Myocardial Infarction: Is There a Winner?

被引：1
作者：
Lee, Hak Seung
Kang, Jeehoon [1 ]
机构：
[1] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
来源：
KOREAN CIRCULATION JOURNAL | 2020年 / 50卷 / 11期
关键词：
RECEPTOR BLOCKERS; CAPTOPRIL; OUTCOMES; TRIAL;
D O I：
10.4070/kcj.2020.0398
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：995 / 997
页数：3
相关论文
共 10 条
  • [1] COLLINS R, 1995, LANCET, V345, P669
  • [2] The OPTIMAL trial: losartan or captopril after acute myocardial infarction
    Gayet, JL
    [J]. LANCET, 2002, 360 (9348) : 1884 - 1885
  • [3] More about the "ARB MI paradox"
    Hall, Alistair S.
    Strauss, Martin H.
    [J]. HEART, 2007, 93 (09) : 1011 - 1014
  • [4] 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
    Ibanez, Borja
    James, Stefan
    Agewall, Stefan
    Antunes, Manuel J.
    Bucciarelli-Ducci, Chiara
    Bueno, Hector
    Caforio, Alida L. P.
    Crea, Filippo
    Goudevenos, John A.
    Halvorsen, Sigrun
    Hindricks, Gerhard
    Kastrati, Adnan
    Lenzen, Mattie J.
    Prescott, Eva
    Roffi, Marco
    Valgimigli, Marco
    Varenhorst, Christoph
    Vranckx, Pascal
    Widimsky, Petr
    [J]. KARDIOLOGIA POLSKA, 2018, 76 (02) : 229 - 313
  • [5] Impact of Angiotensin II Receptor Blockers on Clinical Outcomes after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction Based on Data from the Korean National Health Insurance Database (2005-2014)
    Kim, Gwang Sil
    Ko, Young-Guk
    Suh, Yongsung
    Won, Hoyoun
    Hong, Sung-Jin
    Ahn, Chul-Min
    Kim, Jung-Sun
    Kim, Byeong-Keuk
    Choi, Donghoon
    Hong, Myeong-Ki
    Jang, Yangsoo
    [J]. KOREAN CIRCULATION JOURNAL, 2020, 50 (11) : 984 - 994
  • [6] Angiotensin II Type 1 Receptor Blocker, Fimasartan, Reduces Vascular Smooth Muscle Cell Senescence by Inhibiting the CYR61 Signaling Pathway
    Kim, Inho
    Park, Chan Soon
    Lee, Hae-Young
    [J]. KOREAN CIRCULATION JOURNAL, 2019, 49 (07) : 615 - 626
  • [7] The effects of sacubitril/valsartan on coronary outcomes in PARADIGM-HF
    Mogensen, Ulrik M.
    Kober, Lars
    Kristensen, Soren L.
    Jhund, Pardeep S.
    Gong, Jianjian
    Lefkowitz, Martin P.
    Rizkala, Adel R.
    Rouleau, Jean L.
    Shi, Victor C.
    Swedberg, Karl
    Zile, Michael R.
    Solomon, Scott D.
    Packer, Milton
    McMurray, John J. V.
    [J]. AMERICAN HEART JOURNAL, 2017, 188 : 35 - 41
  • [8] Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
    Pfeffer, MA
    McMurray, JJV
    Velazquez, EJ
    Rouleau, JL
    Kober, L
    Maggioni, AP
    Solomon, SD
    Swedberg, K
    Van de Werf, F
    White, H
    Leimberger, JD
    Henis, M
    Edwards, S
    Zelenkofske, S
    Sellers, MA
    Califf, RM
    Aylward, P
    Armstrong, P
    Barvik, S
    Belenkov, Y
    Dalby, A
    Diaz, R
    Drexler, H
    Ertl, G
    Francis, G
    Hampton, J
    Harsanyi, A
    Kvasnicka, J
    Mareev, V
    Marin-Neto, J
    Murin, J
    Myers, M
    Nordlander, R
    Opolski, G
    Soler-Soler, J
    Spac, J
    Stefenelli, T
    Sugrue, D
    Van Gilst, W
    Varshavsky, S
    Weaver, D
    Zannad, F
    Aguilar, D
    Alvarez, A
    Al-Taweel, M
    Anavekar, N
    Finn, P
    Lopez-Jimenez, F
    Mercier, R
    Lewis, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (20) : 1893 - 1906
  • [9] Angiotensin receptor blockers may increase risk of myocardial infarction: Unraveling the ARB-MI paradox
    Strauss, Martin H.
    Hall, Alistair S.
    [J]. CIRCULATION, 2006, 114 (08) : 838 - 854
  • [10] Clinical Impact of Beta Blockers in Patients with Myocardial Infarction from the Korean National Health Insurance Database
    Won, Hoyoun
    Suh, Yongsung
    Kim, Gwang Sil
    Ko, Young-Guk
    Hong, Myeong-Ki
    [J]. KOREAN CIRCULATION JOURNAL, 2020, 50 (06) : 499 - 508
1